4th Quarter - Report

FERGUSON STRATEGIES, LLC for ENDO PHARMACEUTICALS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policy issues relating to a proposed FDA regulation on generic drug labeling. Policy issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Policy issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Medical Device User Free program.

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.